Protalix BioTherapeutics, Inc. Shares Issued
Protalix BioTherapeutics, Inc. (PLX) had Shares Issued of 80.43 million shares as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-03-18
- 2025-12-31: Common Stock, Shares, Issued 80.43M shares.
- 2024-12-31: Common Stock, Shares, Issued 75.85M shares.
- 2023-12-31: Common Stock, Shares, Issued 72.95M shares.
- 2022-12-31: Common Stock, Shares, Issued 53.79M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2025-12-31 | 80.43M shares 10-K · filed 2026-03-18 | |
| 2024-12-31 | 75.85M shares 10-K · filed 2026-03-18 | |
| 2023-12-31 | 72.95M shares 10-K · filed 2025-03-17 | |
| 2022-12-31 | 53.79M shares 10-K · filed 2024-03-14 | |
| 2021-12-31 | 45.56M shares 10-K · filed 2023-02-27 | |
| 2020-12-31 | 34.77M shares 10-K · filed 2022-03-31 | |
| 2019-12-31 | 14.84M shares 10-K · filed 2021-03-30 | |
| 2018-12-31 | 14.84M shares 10-K · filed 2020-03-12 | 148.38M shares 10-K · filed 2019-03-18 |
| 2017-12-31 | 143.73M shares 10-K · filed 2019-03-18 | |
| 2016-12-31 | 124.13M shares 10-K · filed 2018-03-06 | |
| 2015-12-31 | 99.80M shares 10-K · filed 2017-03-16 | |
| 2014-12-31 | 93.60M shares 10-K · filed 2016-03-08 | |
| 2013-12-31 | 93.55M shares 10-K · filed 2015-03-12 | |
| 2012-12-31 | 93.49M shares 10-K · filed 2014-03-13 | |
| 2012-02-22 | 5.17M shares 10-K · filed 2014-03-13 | |
| 2011-12-31 | 85.63M shares 10-K · filed 2013-02-28 | |
| 2011-03-23 | 4.00M shares 10-K · filed 2014-03-13 | |
| 2010-12-31 | 81.25M shares 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |